Abstract 11676: High-sensitive C-reactive Protein Does Not Predict Early and 1-year Outcomes After Coronary Artery Bypass

Introduction: High-sensitive C-reactive protein (hsCRP) is an inflammtory marker of patients with coronary heart disease but there is still conflicting data on its impact on early and midterm outcomes after isolated coronary artery bypass grafting (CABG). Hypothesis: Preoperative elevated hsCRP is not an independent predictor of cardiovascular events after CABG surgery. Methods: We prospectively analysed data of consecutive 400 patients that underwent elective, isolated CABG between 2012 to 2016 within the randomized-controlled StaRT-CABG trial. Patients were subdivided into a low (2.5mg/l) versus high hsCRP group (>2.5mg/l) as assessed at hospital admission. The primary endpoint was a composite including all-cause mortality, myocardial infarction and cerebrovascular events (MACCE) at 30 days and 1-year survival was assessed. Results: After CABG surgery through postoperative day 30, 5 patients (1.3%) died and 102 patients (25.5%) suffered major morbidity. One-year survival was 96.5% (14 deaths). Univariab...